Adams, S. ( 1982) Amitriptyline suppositories. N Engl J Med306: 996.
2.
Amsterdam, JD, Bodkin, JA ( 2006) Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial. J Clin Psychopharmacol26: 579-586.
3.
Azzaro, AJ, Ziemniak, J., Kemper, E., Campbell, BJ, VanDenBerg, C. ( 2007) Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules. J Clin Pharmacol47: 1256-1267.
4.
Baumann, P., Nil, R., Bertschy, G., Jecker, A., Brandli, H., Morand, J., et al. (1998) A double-blind double-dummy study of citalopram comparing infusion versus oral administration. J Affect Disord49: 203-210.
5.
Blackwell, B. ( 1963) Hypertensive crisis due to monoamine-oxidase inhibitors . Lancet2: 849-850.
6.
Bouchard, JM, Strub, N., Nil, R. ( 1997) Citalopram and viloxazine in the treatment of depression by means of slow drop infusion. A double-blind comparative trial. J Affect Disord46: 51-58.
7.
Bristol-Myers Squibb (2008) Emsam (selegiline transdermal system) - continuous delivery for once-daily application. http://www.bms.com (accessed on 17th November 2008).
8.
Chaumeil, JC, Khoury, JM, Zuber, M., Courteille, F., Piraube, C., Gard, C., et al. (1988) Formulation of suppositories containing imipramine and clomipramine chlorhydrates. Drug Dev Ind Pharm14: 2225-2239.
9.
Christopher, EJ ( 2003) Electroconvulsive therapy in the medically ill . Curr Psychiatry Rep5: 225-230.
10.
Cipriani, A., Geddes, JR, Furukawa, TA, Barbui, C. ( 2007) Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Can J Psychiatry52: 553-562.
11.
Deisenhammer, EA, Whitworth, AB, Geretsegger, C., Kurzthaler, I., Gritsch, S., Miller, CH, et al. (2000) Intravenous versus oral administration of amitriptyline in patients with major depression. J Clin Psychopharmacol20: 417-422.
12.
Department of Health (2008) Code of practice: Mental Health Act 1983-2008 revision. http://www.dh.gov.uk/ (accessed on 24th November 2008).
13.
Fallon, BA, Liebowitz, MR, Campeas, R., Schneier, FR, Marshall, R., Davies, S., et al. (1998) Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Arch Gen Psychiatry55: 918-924.
14.
Fridrich, P., Colvin, HP, Zizza, A., Wasan, AD, Lukanich, J., Lirk, P., et al. (2007) Phase 1A safety assessment of intravenous amitriptyline. J Pain8: 549-555.
15.
Guelfi, JD, Strub, N., Loft, H. ( 2000) Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial. J Affect Disord58: 201-209.
16.
Guthrie, E. ( 2006) Psychological treatments in liaison psychiatry: the evidence base. Clin Med6: 544-547.
17.
Kasper, S., Muller-Spahn, F. ( 2002) Intravenous antidepressant treatment: focus on citalopram . Eur Arch Psychiatry Clin Neurosci252: 105-109.
18.
Konstantinidis, A., Stastny, J., Ptak-Butta, J., Hilger, E., Winkler, D., Barnas, C., et al. (2002) Intravenous mirtazapine in the treatment of depressed inpatients. Eur Neuropsychopharmacol12: 57-60.
19.
Koran, LM, Pallanti, S., Paiva, RS, Quercioli, L. ( 1998) Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder. Eur Neuropsychopharmacol8: 121-126.
20.
Koran, LM, Sallee, FR, Pallanti, S. ( 1997) Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. Am J Psychiatry154: 396-401.
21.
Lundbeck Limited (2007) Summary of product characteristics - cipramil concentrate for solution for infusion 40mg/ml. http://www.lundbeck.com (accessed on 17th November 2008).
22.
Maltese, TM ( 1999) Adjunctive lamotrigine treatment for major depression. (Letter)Am J Psychiatry156: 1833.
23.
Mann, JJ, Aarons, SF, Wilner, PJ, Keilp, JG, Sweeney, JA, Pearlstein, T., et al. (1989) A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor . Arch Gen Psychiatry46: 45-50.
24.
Mirassou, MM ( 1998) Rectal antidepressant medication in the treatment of depression . J Clin Psychiatry59: 29.
Muhlbacher, M., Konstantinidis, A., Kasper, S., Eichberger, G., Hinterhuber, H., Hofmann, P., et al. (2006) Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients. Neuropsychobiology53: 83-87.
27.
National Institute for Clinical Excellence ( 2003) Electroconvulsive therapy (ECT): guidance. Technology Appraisal 59. http://www.nice.org.uk (accessed on 10th November 2008).
28.
Nutt, DJ, Sharpe, M. ( 2008) Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol22: 3-6. Organon (2005) Remergil Konzentrat. http://www.organon.co.uk (accessed on 24th November 2008).
29.
Pallanti, S., Quercioli, L., Koran, LM ( 2002) Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial. J Clin Psychiatry63: 796-801.
30.
Pollock, BG, Perel, JM, Nathan, RS, Kupfer, DJ ( 1989) Acute antidepressant effect following pulse loading with intravenous and oral clomipramine. Arch Gen Psychiatry46: 29-35.
31.
Robinson, DS, Amsterdam, JD ( 2008) The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability. J Affect Disord105: 15-23.
32.
RX List ( 2008) Elavil (amitriptyline HCI). http://www.rxlist.com (accessed on 17th November 2008).
33.
Sallee, FR, Vrindavanam, NS as-Nesmith, D., Carson, SW, Sethuraman, G. ( 1997) Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry154: 668-673.
34.
Seaman, JS, Bowers, SP, Dixon, P., Schindler, L. ( 2005) Dissolution of common psychiatric medications in a roux-en-y gastric bypass model. Psychosomatics46: 250-253.
35.
Severijnen, R., Bayat, N., Bakker, H., Tolboom, J., Bongaerts, G. ( 2004) Enteral drug absorption in patients with short small bowel: a review. Clin Pharmacokinet43: 951-962.
36.
Storey, P., Trumble, M. ( 1992) Rectal doxepin and carbamazepine therapy in patients with cancer. N Engl J Med327: 1318-1319.
37.
Sunderland, T., Cohen, RM, Molchan, S., Lawlor, BA, Mellow, AM, Newhouse, PA, et al. (1994) High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry51: 607-615.
38.
Svestka, J., Ceskova, E., Kamenicka, V., Buresova, A., Obrovska, V., Synek, O. ( 1993) [Citalopram (Seropram) in tablet and infusion forms in the treatment of major depression]Cesk Psychiatr89: 331-339.
39.
Wecker, L., James, S., Copeland, N., Pacheco, MA ( 2003) Transdermal selegiline: targeted effects on monoamine oxidases in the brain. Biol Psychiatry54: 1099-1104.